These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25974193)

  • 21. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
    Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Radiofrequency Catheter Ablation Between Asymptomatic and Symptomatic Persistent Atrial Fibrillation: A Propensity Score Matched Analysis.
    Wu L; Lu Y; Zheng L; Qiao YU; Chen G; Ding L; Hou B; Sun W; Liew R; Zhang S; Yao Y
    J Cardiovasc Electrophysiol; 2016 May; 27(5):531-5. PubMed ID: 26773415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
    Miyazawa K; Pastori D; Lip GYH
    Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
    Boriani G; Pettorelli D
    Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
    O'Neal WT; Efird JT; Judd SE; McClure LA; Howard VJ; Howard G; Soliman EZ
    Clin Cardiol; 2016 Feb; 39(2):103-10. PubMed ID: 26880475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study.
    Gamst J; Christiansen CF; Rasmussen BS; Rasmussen LH; Thomsen RW
    Crit Care; 2015 Aug; 19(1):299. PubMed ID: 26286550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis.
    Wagstaff AJ; Overvad TF; Lip GY; Lane DA
    QJM; 2014 Dec; 107(12):955-67. PubMed ID: 24633256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials.
    Caldeira D; David C; Sampaio C
    Arch Cardiovasc Dis; 2012 Apr; 105(4):226-38. PubMed ID: 22633297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymptomatic atrial fibrillation burden and thromboembolic events: piecing evidence together.
    Proietti R; Labos C; AlTurki A; Essebag V; Glotzer TV; Verma A
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):761-9. PubMed ID: 26894263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.
    Verma A; Champagne J; Sapp J; Essebag V; Novak P; Skanes A; Morillo CA; Khaykin Y; Birnie D
    JAMA Intern Med; 2013 Jan; 173(2):149-56. PubMed ID: 23266597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.
    Liew A; O'Donnell M; Douketis J
    J Thromb Haemost; 2014 Sep; 12(9):1419-24. PubMed ID: 24986568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
    Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative and absolute risks of all-cause and cause-specific deaths attributable to atrial fibrillation in middle-aged and elderly community dwellers.
    Ohsawa M; Okamura T; Ogasawara K; Ogawa A; Fujioka T; Tanno K; Yonekura Y; Omama S; Turin TC; Itai K; Ishibashi Y; Morino Y; Itoh T; Miyamatsu N; Onoda T; Kuribayashi T; Makita S; Yoshida Y; Nakamura M; Tanaka F; Ohta M; Sakata K; Okayama A
    Int J Cardiol; 2015 Apr; 184():692-698. PubMed ID: 25771238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.
    Gupta DK; Giugliano RP; Ruff CT; Claggett B; Murphy S; Antman E; Mercuri MF; Braunwald E; Solomon SD;
    J Am Soc Echocardiogr; 2016 Jun; 29(6):537-44. PubMed ID: 27106009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Jacobs V; Mallender C; Muhlestein JB; Osborn JS; Weiss JP; Day JD
    J Interv Card Electrophysiol; 2016 Sep; 46(3):259-65. PubMed ID: 27207256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
    Glotzer TV; Ziegler PD
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S14-23. PubMed ID: 23790594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.